SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (465)3/10/1999 11:50:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 613
 
FYI Genomics referenced on Raging Bull. Not posted for great technical insight (I usually refer to this forum as Raving since most of the participants on threads I occasionally follow are gullible x e3) but rather to show that maybe the larger investing public may get ahold of what you've been discussing. Scott

ragingbull.com




To: Mike McFarland who wrote (465)3/11/1999 11:29:00 PM
From: WWS  Read Replies (1) | Respond to of 613
 
Mike, my own despair w/biotechs (altho I own fewer shares and in fewer companies than you--VMRX,CTII,CRXA,LGND) has just now led me to eschew science in favor of superstition. No joke. As of today I'm proud owner of RXSD, bought mainly for their distribution of Cellasene (big news, this one), but also for Osteo-biflex, creatinine, chromium picolate, echinacea, gingo biloba etc.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News